» Articles » PMID: 9736031

Transfer of Tumor Necrosis Factor-alpha to Rat Lung Induces Severe Pulmonary Inflammation and Patchy Interstitial Fibrogenesis with Induction of Transforming Growth Factor-beta1 and Myofibroblasts

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1998 Sep 15
PMID 9736031
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor necrosis factor-alpha is up-regulated in a variety of different human immune-inflammatory and fibrotic pulmonary pathologies. However, its precise role in these pathologies and, in particular, the mechanism(s) by which it may induce fibrogenesis are not yet elucidated. Using a replication-deficient adenovirus to transfer the cDNA of tumor necrosis factor-alpha to rat lung, we have been able to study the effect of transient but prolonged (7 to 10 days) overexpression of tumor necrosis factor-alpha in normal adult pulmonary tissue. We have demonstrated that local overexpression resulted in severe pulmonary inflammation with significant increases in neutrophils, macrophages, and lymphocytes and, to a lesser extent, eosinophils, with a peak at day 7. By day 14, the inflammatory cell accumulation had declined, and fibrogenesis became evident, with fibroblast accumulation and deposition of extracellular matrix proteins. Fibrotic changes were patchy but persisted to beyond day 64. To elucidate the mechanism underlying this fibrogenesis, we examined bronchoalveolar fluids for the presence of the fibrogenic cytokine transforming growth factor-beta1 and tissues for induction of alpha-smooth muscle actin-rich myofibroblasts. Transforming growth factor-beta1 was transiently elevated from day 7 (peak at day 14) immediately preceding the onset of fibrogenesis. Furthermore, there was a striking accumulation of myofibroblasts from day 7, with the most extensive and intense immunostaining at day 14, ie, coincident with the up-regulation of transforming growth factor-beta1 and onset of fibrogenesis. Thus, we have provided a model of tumor necrosis factor-alpha-mediated pulmonary inflammation and fibrosis in normal adult lung, and we suggest that the fibrogenesis may be mediated by the secondary up-regulation of transforming growth factor-beta1 and induction of pulmonary myofibroblasts.

Citing Articles

The Plastic Interplay between Lung Regeneration Phenomena and Fibrotic Evolution: Current Challenges and Novel Therapeutic Perspectives.

Lettieri S, Bertuccio F, Del Frate L, Perrotta F, Corsico A, Stella G Int J Mol Sci. 2024; 25(1).

PMID: 38203718 PMC: 10779349. DOI: 10.3390/ijms25010547.


Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension.

Hadi D, Marsool M, Marsool A, Vora N, Al-Badri S, Al-Fatlawi N Immun Inflamm Dis. 2023; 11(11):e1079.

PMID: 38018591 PMC: 10632947. DOI: 10.1002/iid3.1079.


Superiority of systemic bleomycin to intradermal HOCl for the study of interstitial lung disease.

Morozan A, Joy S, Fujii U, Fraser R, Watters K, Martin J Sci Rep. 2023; 13(1):20577.

PMID: 37996447 PMC: 10667597. DOI: 10.1038/s41598-023-47083-y.


Targeting the NLRP3 inflammasome and associated cytokines in scleroderma associated interstitial lung disease.

Woo S, Gandhi S, Ghincea A, Saber T, Lee C, Ryu C Front Cell Dev Biol. 2023; 11:1254904.

PMID: 37849737 PMC: 10577231. DOI: 10.3389/fcell.2023.1254904.


A novel quantification method of lung fibrosis based on Micro-CT images developed with the optimized pulmonary fibrosis mice model induced by bleomycin.

Yang X, Huang X, Chen Z, Xu A, Zhou H, Bi X Heliyon. 2023; 9(3):e13598.

PMID: 36895392 PMC: 9988492. DOI: 10.1016/j.heliyon.2023.e13598.


References
1.
Piguet P, Ribaux C, Karpuz V, Grau G, KAPANCI Y . Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis. Am J Pathol. 1993; 143(3):651-5. PMC: 1887194. View

2.
Phan S, Kunkel S . Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res. 1992; 18(1):29-43. DOI: 10.3109/01902149209020649. View

3.
Mauviel A, Daireaux M, Redini F, Galera P, LOYAU G, Pujol J . Tumor necrosis factor inhibits collagen and fibronectin synthesis in human dermal fibroblasts. FEBS Lett. 1988; 236(1):47-52. DOI: 10.1016/0014-5793(88)80283-7. View

4.
Piguet P, Vesin C . Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Respir J. 1994; 7(3):515-8. DOI: 10.1183/09031936.94.07030515. View

5.
Piguet P, Collart M, Grau G, Sappino A, Vassalli P . Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature. 1990; 344(6263):245-7. DOI: 10.1038/344245a0. View